LEVI - Levi Strauss & Co.
NYSE
->
Consumer Cyclical
->
Apparel Manufacturing
San Francisco,
United States
Type: Equity
LEVI price evolution
LEVI
| (in millions $) | 25 Sep 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $641.4 | $516.7 | $398.8 | |
| Short term investments | ||||
| Net receivables | $679.5 | $581.8 | $661.6 | $752.7 |
| Inventory | $1275.2 | $1220 | $1150.4 | $1290.1 |
| Total current assets | $2745.5 | $2650 | $2524.8 | $2637.6 |
| Long term investments | ||||
| Property, plant & equipment | $1802.1 | $1749.1 | $1695.3 | $1714.6 |
| Goodwill & intangible assets | $593 | $562.3 | $571.3 | |
| Total noncurrent assets | $3535.9 | $3436.7 | $3416 | |
| Total investments | ||||
| Total assets | $6253.5 | $6185.9 | $5961.5 | $6053.6 |
| Current liabilities | ||||
| Accounts payable | $667.8 | $623.1 | $497.6 | $567.9 |
| Deferred revenue | ||||
| Short long term debt | $246 | $245.6 | $245.5 | |
| Total current liabilities | $1946.1 | $1869.1 | $1770.4 | $1787.5 |
| Long term debt | $1020.5 | $1943.8 | $1903.8 | $1922.5 |
| Total noncurrent liabilities | $2363.1 | $2215 | $2219.7 | |
| Total debt | $2189.8 | $2149.4 | $2168 | |
| Total liabilities | $4380.4 | $4232.2 | $3985.4 | $4007.2 |
| Shareholders' equity | ||||
| Retained earnings | $1571.2 | $1620 | $1666.7 | $1750.2 |
| Other shareholder equity | -$418.5 | -$374.7 | -$383.3 | -$390.9 |
| Total shareholder equity | $1953.7 | $1976.1 | $2046.4 | |
| (in millions $) | 31 Dec 2023 | 27 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $398.8 | $429.6 | $810.27 | $1497.15 |
| Short term investments | $70.6 | $91.55 | $96.53 | |
| Net receivables | $752.7 | $697 | $707.63 | $540.23 |
| Inventory | $1290.1 | $1416.8 | $897.95 | $817.69 |
| Total current assets | $2637.6 | $2827.9 | $2709.9 | $3126.24 |
| Long term investments | ||||
| Property, plant & equipment | $1714.6 | $1592.8 | $1606.27 | $1443.33 |
| Goodwill & intangible assets | $571.3 | $652.4 | $678.21 | $312.19 |
| Total noncurrent assets | $3416 | $3209.9 | $3190.17 | $2515 |
| Total investments | $70.6 | $91.55 | $96.53 | |
| Total assets | $6053.6 | $6037.8 | $5900.07 | $5641.24 |
| Current liabilities | ||||
| Accounts payable | $567.9 | $657.2 | $524.84 | $375.45 |
| Deferred revenue | ||||
| Short long term debt | $245.5 | $235.7 | $251.23 | $254.77 |
| Total current liabilities | $1787.5 | $1981.6 | $1869.62 | $1548.88 |
| Long term debt | $1922.5 | $984.5 | $1990.18 | $2404.99 |
| Total noncurrent liabilities | $2219.7 | $2152.5 | $2364.79 | $2792.88 |
| Total debt | $2168 | $2079.3 | $2241.41 | $2659.77 |
| Total liabilities | $4007.2 | $4134.1 | $4234.41 | $4341.77 |
| Shareholders' equity | ||||
| Retained earnings | $1750.2 | $1699.4 | $1474.87 | $1114.28 |
| Other shareholder equity | -$390.9 | -$421 | -$394.39 | -$441.45 |
| Total shareholder equity | $2046.4 | $1903.7 | $1665.66 | $1299.47 |
| (in millions $) | 25 Sep 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1516.8 | $1441.2 | $1557.6 | $1642.3 |
| Cost of revenue | $569.5 | $651.1 | $692.6 | |
| Gross Profit | $910.7 | $871.7 | $906.5 | $949.7 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $794.7 | $790.7 | $798.5 | |
| Total operating expenses | $765.6 | $849.8 | $906.9 | $798.5 |
| Operating income | $21.9 | -$0.4 | $151.2 | |
| Income from continuing operations | ||||
| EBIT | $22.3 | -$2.7 | $147.1 | |
| Income tax expense | -$0.9 | -$6 | -$2.1 | $9.7 |
| Interest expense | -$10.1 | $10.3 | $10 | $10.5 |
| Net income | ||||
| Net income | $20.7 | $18 | -$10.6 | $126.9 |
| Income (for common shares) | $18 | -$10.6 | $126.9 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $6179 | $6168.6 | $5763.94 | $4452.61 |
| Cost of revenue | $2663.3 | $2619.8 | $2417.22 | $2099.68 |
| Gross Profit | $3515.7 | $3548.8 | $3346.71 | $2352.92 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $3072.2 | $2893.2 | $2652.21 | $2347.63 |
| Total operating expenses | $3162.4 | $2902.3 | $2660.5 | $2438.04 |
| Operating income | $353.3 | $646.5 | $686.21 | -$85.12 |
| Income from continuing operations | ||||
| EBIT | $311.1 | $675.3 | $653.14 | -$107.59 |
| Income tax expense | $15.6 | $80.5 | $26.7 | -$62.64 |
| Interest expense | $45.9 | $25.7 | $72.9 | $82.19 |
| Net income | ||||
| Net income | $249.6 | $569.1 | $553.54 | -$127.14 |
| Income (for common shares) | $249.6 | $569.1 | $553.54 | -$127.14 |
| (in millions $) | 25 Sep 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $18 | -$10.6 | $126.9 | |
| Operating activities | ||||
| Depreciation | $44.1 | $44.6 | $43.1 | |
| Business acquisitions & disposals | -$34.4 | -$12.1 | ||
| Stock-based compensation | $16.8 | $18.7 | $18 | |
| Total cash flows from operations | $262.8 | $286 | $258.9 | |
| Investing activities | ||||
| Capital expenditures | -$40.2 | -$71.6 | -$56.5 | |
| Investments | $5.1 | $0.8 | -$11.2 | |
| Total cash flows from investing | -$192.2 | -$69.7 | -$71.7 | -$79.8 |
| Financing activities | ||||
| Dividends paid | -$147.1 | -$47.7 | -$47.9 | -$47.6 |
| Sale and purchase of stock | -$16.9 | -$25 | ||
| Net borrowings | -$25 | |||
| Total cash flows from financing | -$229.1 | -$68.4 | -$94.5 | -$75 |
| Effect of exchange rate | -$1.5 | -$1.9 | $0.2 | |
| Change in cash and equivalents | $178.3 | $124.7 | $117.9 | $104.3 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $249.6 | $569.1 | $553.54 | -$127.14 |
| Operating activities | ||||
| Depreciation | $165.3 | $158.9 | $143.17 | $141.79 |
| Business acquisitions & disposals | -$12.1 | -$390.92 | -$54.57 | |
| Stock-based compensation | $74.4 | $60.8 | $60.07 | $50.95 |
| Total cash flows from operations | $435.5 | $228.1 | $737.26 | $469.59 |
| Investing activities | ||||
| Capital expenditures | -$315.5 | -$267.1 | -$166.94 | -$130.38 |
| Investments | $86.9 | $32.6 | -$13.95 | -$3.61 |
| Total cash flows from investing | -$240.7 | -$235.7 | -$571.81 | -$188.56 |
| Financing activities | ||||
| Dividends paid | -$190.5 | -$174.3 | -$104.43 | -$63.64 |
| Sale and purchase of stock | -$8.1 | -$175.7 | -$78.19 | -$48.19 |
| Net borrowings | $7.4 | -$546.23 | $506.09 | |
| Total cash flows from financing | -$214.1 | -$365.4 | -$840.89 | $286 |
| Effect of exchange rate | -$11.6 | -$7.6 | -$11.63 | -$4.13 |
| Change in cash and equivalents | -$30.9 | -$380.6 | -$687.07 | $562.89 |
News
Fundamentals
| Market cap | $8.00B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 396.73M |
| Revenue | $6.16B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $155.00M |
| Revenue Q/Q | 0.38% |
| Revenue Y/Y | 0.53% |
| P/E ratio | 51.60 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 1.30 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $0.39 |
|---|---|
| ROA | 2.54% |
| ROE | N/A |
| Debt/Equity | 1.96 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.41 |
| Quick ratio | 0.76 |